Mineralys Therapeutics, Inc. (MLYS)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
25. 57
-0.1
-0.3896%
$
2.26B Market Cap
- P/E Ratio
- Div Yield
728,420 Volume
-2.58 Eps
$ 25.67
Previous Close 
Want to track MLYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mineralys Therapeutics, Inc. (MLYS) Q2 2024 Earnings Call Transcript
Mineralys Therapeutics, Inc. (NASDAQ:MLYS ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Dan Ferry - LifeSci Advisors Jon Congleton - Chief Executive Officer Adam Levy - Chief Financial Officer David Rodman - Chief Medical Officer Conference Call Participants Michael DiFiore - Evercore Richard Law - Goldman Sachs Annabel Samimy - Stifel Mohit Bansal - Wells Fargo Rami Katkhuda - LifeSci Capital Operator Welcome to the Mineralys Therapeutics Second Quarter 2024 Conference Call. At this time all lines are in a listen-only mode.
Seekingalpha | 2 years ago
